Experiment 1119768

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

ANGUIDINE

Alerts

THESE DATA ARE FROM A REVIEW ARTICLE.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationANON:. (1982). TABULAR SUMMARY OF 1981 CLINICAL TRIALS LETTERS (PUBLISHED IN VOLUME 65 OF CANCER TREATMENT REPORTS).. 66()
Amount utilized
Compound isolated
DiseaseDAILY DOSING FOR 5 DAYS EVERY 28 DAYS. USED IN COMBINATION WITH 5-FU. USED IN 30 CASES OF COLORECTAL CANCER. TWO PARTIAL RESPONSES.
Dose amount2.5 MG
Number1
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE